No recent analyst price targets found for SPHDF.
Latest News for SPHDF
Santhera nears cash break-even as AGAMREE gains traction, Edison says
Santhera Pharmaceuticals (SIX:SANN, OTC:SPHDF, FRA:S3F0), the Swiss rare-disease drugmaker, is closing in on a financial turning point, according to research house Edison. In a QuickView note published on Tuesday, analysts Jyoti Prakash and Arron Aatkar said the company was on track to reach cash flow break-even in the third quarter, completing its shift into a self-funded business.
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for SPHDF.
Senate Trading
No Senate trades found for SPHDF.
U.S. House Trading
No House trades found for SPHDF.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.